ArticleActa oncologica (Stockholm, Sweden)2013

Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.

Mona-Elisabeth Revheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.